HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: db07-0863v1 57/3/614    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shapiro, A. Articles by Scarpace, P. J. Search for Related Content PubMed PubMed Citation Articles by Shapiro, A. Articles by Scarpace, P. J. Related Collections Related Article Social Bookmarking                What's this?

Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin resistant rats

¹Department of Pharmacology and Therapeutics
²Department of Aging and Geriatrics
³Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32610
⁴Department of Veterans Affairs Medical Center, Gainesville, Florida 32608-1197

Objective: We examined whether chronic leptin treatment of diet-induced obese (DIO) rats promotes or alleviates the susceptibility to continued high-fat (HF) feeding. Secondly, we examined if voluntary wheel running (WR) is beneficial in reducing the trajectory of weight gain in HF-raised leptin resistant rats.

Research Design and Methods: Sprague-Dawley rats were chow or HF fed for five months, and then hypothalamic leptin overexpression was induced through central administration of rAAV-leptin while continuing either chow or HF diet. Two weeks later, half of the rats in each group were provided access to running wheels for 38 days, whilst maintained on either chow or HF.

Results: In chow-raised rats, either WR or leptin reduced the trajectory of weight gain, and the combined effect of both treatments was additive. In HF-raised leptin-resistant rats, leptin overexpression first transiently reduced weight gain, but then accelerated the weight gain 2-fold over controls. WR in HF-raised was 6-fold less than in chow raised rats and did not affect the weight gain. Surprisingly, WR plus leptin completely prevented the weight gain. This synergy was associated with enhanced hypothalamic signal transducer and activator of transcription 3 (STAT3) phosphorylation and suppressor of cytokine signaling 3 (SOCS3) expression in the WR plus leptin compared with leptin-treated sedentary HF counterparts. This enhanced STAT3 signaling associated with the combination treatment occurred only in HF-raised, leptin-resistant, and not in chow-raised, leptin-responsive rats.

Conclusions: Chronic leptin treatment in diet-induced obese rats accelerates dietary obesity. However, leptin combined with WR prevents further dietary weight gain. Thus, this combination therapy may be a viable anti-obesity treatment.

Key Words: Central leptin gene therapy • diet-induced obesity • leptin resistance • STAT3 phosphorylation • voluntary wheel running

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article:

Interaction Between Exercise and Leptin in the Treatment of Obesity

Christopher Morrison
Diabetes 2008 57: 534-535. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				C. Morrison Interaction Between Exercise and Leptin in the Treatment of Obesity Diabetes, March 1, 2008; 57(3): 534 - 535. [Full Text] [PDF]